| venlafaxine extended release / Generic mfg. |
NCT01282801: Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Under Fed Conditions |
|
|
| Completed | 1 | 18 | Canada | Venlafaxine Hydrochloride, Effexor® XR, Venlafaxine Hydrochloride (generic name) | Teva Pharmaceuticals USA | Healthy | 10/02 | 10/02 | | |
NCT01260896: Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Under Fasting Conditions |
|
|
| Completed | 1 | 24 | Canada | Venlafaxine Hydrochloride, Effexor® XR, Velafaxine Hydrochloride (generic name) | Teva Pharmaceuticals USA | Healthy | 10/02 | 10/02 | | |
NCT01282814: Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Sprinkle Study |
|
|
| Completed | 1 | 24 | Canada | Venlafaxine Hydrochloride, Effexor® XR, Venlafaxine Hydrochloride (generic name) | Teva Pharmaceuticals USA | Healthy | 03/03 | 03/03 | | |
NCT01512459: Bioavailability Study of Venlafaxine MR Capsules 150 mg Under Fed Conditions |
|
|
| Completed | 1 | 33 | RoW | Venlafaxine, Effexor XR | Dr. Reddy's Laboratories Limited | Healthy | 05/06 | 06/06 | | |
NCT00362271: Aripiprazole and Effexor XR Drug Interaction Study |
|
|
| Completed | 1 | 38 | US | Venlafaxine on Day -4 to day 14, Aripiprazole dosed starting on Day 1: 3 days at 10 mg, 4 days at 1 mg and 7 days at 20 mg., Abilify | Otsuka Pharmaceutical Development & Commercialization, Inc. | Healthy | 09/06 | 09/06 | | |
NCT00676039: Comparison of the Pharmacokinetics of Two Generic Antidepressants and Their Respective Brand Preparations |
|
|
| Completed | 1 | 18 | Canada | Venlafaxine, Gen-Citalopram, Effexor XR, Celexa | University of Ottawa | Healthy | 07/08 | 07/08 | | |
NCT00727064: Study Evaluating the Pharmacokinetics of Venlafaxine Extended-Release (ER) and Desvenlafaxine Succinate Sustained-Release (DVS SR) 50 mg in Healthy Subjects |
|
|
| Completed | 1 | 14 | US | Desvenlafaxine Succinate Sustained-Release (DVS SR), Venlafaxine Extended Release (VEN ER) | Wyeth is now a wholly owned subsidiary of Pfizer | Healthy | 08/08 | 08/08 | | |
NCT01235338: Co-Administration of LDX (SPD489) and Venlafaxine XR (EFFEXOR XR) in Healthy Volunteers |
|
|
| Completed | 1 | 80 | US | LDX + Venlafaxine XR, Lisdexamfetamine dimesylate, LDX, Vyvanse, SPD489; Venlafaxine hydrochloride extended-release, Effexor XR,, Venlafaxine XR + LDX, Venlafaxine hydrochloride extended-release, Effexor XR; Lisdexamfetamine dimesylate, LDX, Vyvanse, SPD489 | Shire | Healthy | 12/10 | 01/11 | | |
NCT01418612: Bioequivalence Study of Torrent Pharmaceutical Limited's Venlafaxine Hydrochloride ER Capsules Under Fed Conditions |
|
|
| Completed | 1 | | RoW | Venlafaxine Hydrochloride Extended-Release Capsules of Torrent Pharmaceuticals Limited | Torrent Pharmaceuticals Limited | Healthy | | | | |
NCT01418625: Bioequivalence Study of Torrent Pharmaceutical Limited's Venlafaxine Hydrochloride ER Capsules Under Fed Conditions |
|
|
| Completed | 1 | | RoW | Venlafaxine Hydrochloride Extended-Release Capsules 150mg (Test formulation, Torrent Pharmaceutical Limited., India) | Torrent Pharmaceuticals Limited | Healthy | | | | |
NCT01867255: Study to Examine the Effect of Gastric Bypass Surgery on Venlafaxine ER Blood Levels |
|
|
| Completed | 1 | 10 | US | venlafaxine ER (extended-release) 75 mg, Effexor XR 75 mg | Mayo Clinic | Bariatric Surgery, Gastric Bypass, Roux-en-Y Gastric Bypass | 03/15 | 03/15 | | |
NCT02637193: A Study to Assess The Effects Of Effexor XR On Cardiac Repolarization In Healthy Adult Subjects |
|
|
| Completed | 1 | 54 | US | Venlafaxine, Active drug, Moxifloxacin, Positive control, Drug - placebo, Placebo control | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Healthy Subjects | 07/16 | 07/16 | | |
NCT03274817: A Proof of Concept Study of the Prevention of Mild Cognitive Impairment and Eventual Alzheimer's Disease Using F18 Flutemetamol |
|
|
| Terminated | 1 | 5 | US | Escitalopram Pill, Lexapro, Venlafaxine Pill, Effexor XR, Placebo Oral Tablet | NYU Langone Health | Alzheimer Disease | 09/19 | 09/19 | | |
